Progress in restorative neurosurgery: Human fetal striatal transplantation in Huntington's disease. Review

Journal of Neurosurgical Sciences

Volumn 55, Issue 4, 2011, Pages 371-381

  Gallina, P ^a   Paganini, M ^a   Lombardini, L ^a   Giordano, G ^a   Mascalchi, M ^a   Romoli, A M ^a   Ghelli, E ^a   Porfirio, B ^a   Vannelli, G B ^a   Lorenzo, N D I ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Brain diseases; Huntington disease; Neurosurgery; Transplants

Indexed keywords

ADOPTION; ADULT; AGED; AGRICULTURAL WORKER; CLINICAL RESEARCH; COCHRANE LIBRARY; CONTROLLED STUDY; CORRELATION ANALYSIS; EURYGASTER; HUMAN; INTEGRATED PEST MANAGEMENT; IRAN; MAJOR CLINICAL STUDY; PEST CONTROL; PLANT PEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVIEW; WHEAT;

BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; HUMANS; HUNTINGTON DISEASE; NEURONS;

EID: 84857545068     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Thompson TP, Lunsford, LD, Kondziolka D. Restorative neurosurgery: opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases. Neurosurgery 1999;45:741-52. (Pubitemid 29467801)
2. Elder JB, Hoh DJ, Oh BC, Heller AC, Liu CY, Apuzzo MLJ. The future of cerebral surgery: a kaleidoscope of opportunities. Neurosurgery 2008;62(6 Suppl 3):1359-60.
3. Björklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000;537-44. (Pubitemid 30332071)
4. Liu CY, Apuzzo ML, Tirrell DA. Engineering of the extracellular matrix: working toward neural stem cell programming and neurorestoration. Concepts and progress report. Neurosurgery 2003;52:1154-67. (Pubitemid 36512982)
5. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441:1094-6. (Pubitemid 43990722)
6. Tuszynski MH. Rebuilding the brain: resurgence of fetal grafting. Nat Neurosci 2007;10:1229-30. (Pubitemid 47480286)
7. Lindvall O, Bengzon J, Elmér E, Kokaia M, Kokaia Z. In Functional Neural Transplantation. Dunnet SB, Björklund A, editors. New York: Raven Press; 1994.p. 387-413.
8. Paul G. Cell transplantation for patients with Parkinson's disease. Handb Exp Pharmacol 2006;174:361-88.
9. Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2008;62(Suppl 2):863-74.
10. Freed CR, Paul GE, Breeze RE, Tsai WY, DuMouchel W, Kao R. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-9. (Pubitemid 32204988)
11. Laguna Goya R, Tyers P, Barker RA. The search for a curative cell therapy in Parkinson's disease. J Neurol Sci 2008265:32-42.
12. Novak MJ, Tabrizi SJ. Huntington's disease. BJM 2010;340:c3109.
13. rd ed. Oxford: Oxford University Press; 2002.
14. Groppi C, Barontini F, Bracco L, Sità D, Inzitari D, Amaducci L et al. Huntington's chorea: a prevalence study in the Florence area. Acta Neurol Scand 1986;74:266-8. (Pubitemid 17198882)
15. Rawlins M. Huntington's disease out of the closet ? Comment in Lancet 2010, Jun 29.
16. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE et al. A polymorphic DNA marker genetically linked to Huntington'disease. Nature 1983;306:234-8. (Pubitemid 14232350)
17. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
18. Ferrante R, Kowall NW, Richardson EP. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 1991;11:3877-87.
19. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropath Exp Neurol 1985;44:559-77. (Pubitemid 16196286)
20. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995;68:273-85.
21. Shannon KM, Kordower JH. Neural transplantation for Huntington's disease: Experimental rationale and recommendations for clinical trials. Cell Transplant 1996;5:339-52. (Pubitemid 26096193)
22. Freeman TB, Hauser RA, Willing AE, Zigova T, Sanberg PR, Saporta S. Transplantation of human fetal striatal tissue in Huntingtons's disease: rationale for clinical studies. In: Dunnet SB, editor. Neural transplantation in neurodegenerative disease. Chichester: J. Wiley and Sons Ltd; 2000. p. 129-44.
23. Peschanski M, Bachoud-Lévi AC, Hantraye P. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain 2004;127:1219-28. (Pubitemid 38745503)
24. Clelland CD, Barker RA, Watts C. Cell therapy in Huntington disease. Neurosurg Focus 2008;24:E8.
25. Vonsattel JP, DiFiglia M. Huntington's disease. J Neuropathol Exp Neurol 1998;57:369-84.
26. Thieben MJ, Duggins AJ, Good CD, Gomes N, Mahant N, Richards F. The distribution of structural neuropathology in preclinical Huntington's disease. Brain 2002;125:1815-28.
27. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003;60:1615-20. (Pubitemid 36618087)
28. Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischi B. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131:1057-68. (Pubitemid 351499426)
29. Delia Nave R, Ginestroni A, Tessa C, Giannelli M, Piacentini S, Filippi M. Regional distribution and clinical correlates of white matter microstructural damage in Huntington's disease. AJNR Am J Neuroradiol 2010 [Epub ahead of print].
30. Ginestroni A, Battaglini M, Diciotti S, Delia Nave R, Mazzoni LN, Tessa C et al. Magnetization Transfer MR imaging demonstrates degeneration of subcortical and cortical gray matter in Huntington disease. AJNR Am J Neuroradiol 2010 [Epub ahead of print].
31. Mazurek MF, Garside S, Beal MF. Cortical peptide changes in Huntington's disease may be independent of striatal degeneration. Ann Neurol 1997;41:540-7.
32. Greenamyre JT, Shoulson I. We need something better, and we need it now: fetal striatal transplantation in Huntington's disease? Neurology 2002;58:675-6. (Pubitemid 34211542)
33. Shoulson I, Plassche W, Odoroff C. Huntington's disease: caudate atrophy parallels functional impairment. Neurology 1982;32:143-50.
34. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I. Clinical-pathologic correlation in Huntington's disease. Neurology 1989;39:796-801.
35. Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C. Huntington's disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of the brain. Radiology 2004;232:867-73. (Pubitemid 39100275)
36. Tabrizi SJ, Dur A, Ross RAC, Leavit BR, Jones R, Landwehrmeyer GB et al. Significant biological and clinical changes detected over 1 year in premanifest and early stage Huntington's disease in the TRACK-HD study. Proceedings of Annual Meeting of European Huntington's Disease Network; 2010 Sept 2-5; Prague, Czech Republic. J Neurol Neurosurg Psych 2010;81(Suppl 1):A33.
37. Hayden MR, Martin WRW, Stoess AJ, Clark C, Hollenberg S, Adam MJ et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 1986;36:888-94. (Pubitemid 16098230)
38. Mazziotta JC, Phelps ME, Pahl JJ, Hung SC, Baxter LR, Riege W et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. New Engl J Med 1987;316:357-62. (Pubitemid 17034259)
39. Grafton ST, Mazziotta JC, Pahl JJ, St. George-Hyslop P, Haines JL, Gusella J et al. A comparison of neurological, metabolic, structural and genetic evaluations in persons at risk of Huntington's disease. Ann Neurol 1990;28:614-21. (Pubitemid 20373893)
40. Leenders KL, Frackowiak RJS, Quinn N, Marsden CD. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Movement Disord 1986;1:69-77.
41. Kuwert T, Lange HW, Langen KJ, Herzong H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990;113:1405-23. (Pubitemid 20385921)
42. Weinberger DR, Berman KF, Iadarola M, Driesen N, Zec RF. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiat 1988;51:94-104. (Pubitemid 18055108)
43. Teichmann M, Dupoux E, Kouider S, Brugières P, Boissé MF, Baudic S et al. The role of the striatum in rule application: the model of Huntington's disease at early stage. Brain 2005;128:1155-67. (Pubitemid 40675469)
44. Björklund A, Campbell K, Sinathsinghji RA, Fricker RA, Dunnett SB. Functional capacity of striatal transplants in the rat Huntington model. In: Björklund A, Dunnet SB, editors. Functional neural transplantation. New York, NY: Raven Press; 1994. p. 157-95.
45. Dunnet SB, Nathwani F, Björklund A. The integration and function of striatal grafts. Prog Brain Res 2000;127:345-80.
46. Fricker-Gates RA, Lundberg C, Dunnett SB. Neural transplantation: restoring complex circuitry in the striatum. Review. Restor Neurol Neurosci 2001;19:119-38. (Pubitemid 35025926)
47. Sramka M, Rattaj M, Molina H, Vojtassak J, Belan V, Ruzicky E. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotact Funct Neurosurg 1992;58:79-83.
48. Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F. Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol Res 1995;17:312-5.
49. Philpott LM, Kopyov OV, Lee AJ, Jacques S, Duma CM, Caine S et al. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant 1997;6:203-12. (Pubitemid 27225171)
50. Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998;149:97-108. (Pubitemid 28091019)
51. Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S et al. Bilateral human fetal striatal transplantation in Huntitngton's disease. Neurology 2002;58:687-95. (Pubitemid 34211545)
52. Bachoud-Lévy AC, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 2000;161:194-202. (Pubitemid 30136541)
53. Bachoud-Lévy AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356:1975-9
54. Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK et al. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosur Psychiatry 2002;73:678-85. (Pubitemid 35448852)
55. Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, Bokla L et al. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009;160:661-75.
56. Gallina P, Vannelli G, Paganini M, Lombardini L, Saccardi R, Macucci M et al. Human foetal striatal transplantation in Huntington's disease. First Italian clinical trial at the University of Florence. Preliminary report. Proceedings of the XVIIth Congress of the European Society for Stereotactic and Functional Neurosurgery (ESSFN); 2006 Oct 4-7; Montreux, Switzerland. Acta Neurochir (Wien);2006;48.
57. Gallina P, Vannelli G, Paganini M, Lombardini L, Saccardi R, Macucci M et al. Human fetal striatal transplantation in Huntington's disease. The Italian clinical trial at the University of Florence. Proceedings of the XVIIIth Congress of the European Society for Stereotactic and Functional Neurosurgery (ESSFN); 2008 Oct 6-8; Rimini, Italy. Acta Neurochir (Wien) 2008;150:980.
58. Freeman TB, Sanberg PR, Isacson O. Development of the human striatum. Implications for fetal striatal transplantation in the treatment of Huntington's disease. Cell Transplant 1995;4:539-45.
59. Dunnett SB, Rosser AE. Cell therapy in Huntington's disease. NeuroRx 2004;1:394-405. (Pubitemid 46613777)
60. Deacon TW, Pakzaban P, Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence. Brain Res 1994;668:211-9.
61. Nakao N, Odin P, Brundin P. Selective sub-dissection of the striatal primordium for cultures affect the yield of DARP-32-containing neurones. NeuroReport 1994;5:1081-4. (Pubitemid 24160518)
62. Olson I. Regeneration in the adult central nervous system: experimental repair strategies. Nat Med 1997;3:1329-35.
63. Marin O, Anderson SA, Rubenstein JL. Origin and molecular specification of striatal interneurons. J Neurosci 2000;20:6063-76. (Pubitemid 30658400)
64. Gallina P, Paganini M, Lombardini L, Saccardi R, Marini M, De Cristoforo M et al. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp Neurol 2008;213:241-4.
65. Gallina P, Paganini M, Lombardini L, Mascalchi M, Porfirio B, Gadda D et al. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp Neurol 2010;222:30-41.
66. Björklund A, Stenevi U. Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. Ann Rev Neurosci 1984;7:279-308. (Pubitemid 14155300)
67. Naimi S, Jeny R, Hantraye P, Peschanski M, Riche D. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain. Exp Neurol 1996;137:15-25. (Pubitemid 26041780)
68. Fees-Higgins A, Larroche JC. Development of the human foetal brain: an anatomical atlas. Paris: Masson; 1987.
69. Hurelbrink CB, Armostrong RJE, Barker RA, Dunnett SB, Rosser AE. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant 2000;9:743-9. (Pubitemid 32102064)
70. Rosser AE, Barker RA, Armstrong RJE, Elneil S, Jain M, Hurelbrink CB et al. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease. Cell Transplant 2003;12:679-86. (Pubitemid 37409736)
71. Thajeb P, Ling ZD, Potter ED, Carvey PM. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplant 1997;6:297-307. (Pubitemid 27225180)
72. Negishi T, Ishii Y, Kawamura S, Kuroda Y, Yoshikawa Y. Cryopreservation of brain tissue for primary culture. Exp Anim 2002;51:383-90. (Pubitemid 135695690)
73. Brunet, JF, Pellerin L, Magistretti P, Villemure JP. Cryopreservation of human brain tissue allowing timely production of viable adult human brain cells for autologous transplantation. Cryobiology 2003;47:179-83. (Pubitemid 37315810)
74. Brundin P, Isacson O, Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res 1985;331:251-9. (Pubitemid 15115334)
75. Barker RA, Fricker RA, Abrous DN, Fawcett J, Dunnett SB. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant 1995;4:173-200.
76. Mattson MP, Rychlik B. Cell culture of cryopreserved human fetal cerebral cortical and hippocampal neurons: neuronal development and responses to trophic factors. Brain Res 1990;522:204-14. (Pubitemid 20259771)
77. Frodl EM, Sauer H, Lindvall O, Brundin P. Effects of hibernation or cryopreservation on the survival and integration of striatal grafts placed in the ibotenate-lesioned rat caudate-putamen. Cell Transplant 1995;4:571-7.
78. Palfi S, Nguyen JP, Brugières P, Le Guerinel C, Hantraye P, Remy P et al. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp Neurol 1998;150:272-81. (Pubitemid 28231959)
79. Russchen FT, Bakst I, Amaral DG, Price L. The amygdalostriatal projections in the monkey. An anterograde tracing study. Brain Res 1985;29:241-51.
80. Gallina P, Paganini M, Di Rita A, Lombardini L, Moretti M., Vannelli GB et al. Human fetal striatal transplantation in Huntington's disease: a refinement of the stereotactic procedure. Stereotact Funct Neurosurg 2008;86:308-13.
81. Freed CR, Breeze RE, Schneck SA, Bakay RAE, Ansari AA. Fetal neural transplantation for Parkinson's disease. In Rich RR, editor. Clinical immunology: principles and practice. St Louis, Mosby-Year Book; 1995. p. 1677-87.
82. Bachoud-Lévy AC, Gaura V, Brugières P, Lefaucher JP, Boissé MF, Maison P et al. Effect of fetal neural tranplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006;5:303-9.
83. Cicchetti F, Saporta S, Hauser A, Parent M, Saint-Pierre M, Sanberg PR et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Nat Acad Sci USA 106;12483-8.
84. Krystkowiak P, Gaura V, Labalette M, Rialland, A, Remy, P, Peschanski M et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE 2007;24:2e166.
85. Porfirio B, Pradella F, Rombolà G, Di Lorenzo N, Gallina P, Lombardini L et al. Human foetal striatal transplantation in Huntington's disease: a protocol for the immunogenetic monitoring of the first Italian clinical trial. Tissue Antigens 2008;71:270-1.
86. Favre J, Taha JM, Burchiel KJ. An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures. Neurosurgery 2002;50:48-56. (Pubitemid 41672554)
87. Gaura V, Bachoud-Lévy AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S et al. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2003;127:65-72.
88. Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB et al. Positron emission tomography after transplantation in Huntington's disease. Ann Neurol 2005;58:331-7. (Pubitemid 41098893)
89. Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey C et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 2008;79:948-51.
90. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM et al. Transplanted fetal striatum in Huntington disease: phenotypic development and lack of pathology. Proc Nat Acad Sci USA 2000;97:13877-82.
91. Keene CD, Sonnen JA, Swanson PD, Kopyov O, Reverenz JB, Montine TJ. Neural transplantation in Huntington's disease. Long-term grafts in two patients. Neurology 2007;68:2093-8. (Pubitemid 46912127)
92. Keene CD, Chang RC, Leverenz JB, Kopyiov O, Pelman S, Hevner RF. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 2009;117:329-38.
93. Bachoud-Lévi AC. Neural grafts in Huntitngton's disease:viability after 10 years. Lancet Neurol 2009;8:979-81.
94. Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K et al. Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD). Mov Disord 1996;1:143-50. (Pubitemid 26082780)
95. Huntington's Disease Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996;11:136-42.
96. Döbrössy M, Busse M, Piroth T, Rosser A, Dunnett S, Nikkhah G. Neurorehabilitation with neural transplantation. Neurorehabil Neural Repair 2010 [Epub ahead of print].
97. Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol 2003;2:417-24. (Pubitemid 36793934)
98. Rossi F, Cattaneo E. Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Review. Nat Rev Neurosci 2002;3:401-9. (Pubitemid 135706637)
99. Berninger B, Hack MA, Gotz M. Neural stem cells: on where they hide, in which disguise, and how we may lure them out. A Review. Handb Exp Pharmacol 2006;319-60.
100. Li JY, Christophersen NS, Hall V, Soulet D, Brundin P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008;31:146-53.